A PILOT TRIAL OF GEMCITABINE IN COMBINATION WITH CAPECITABINE OR ERLOTINIB COMPARED TO GEMCITABINE ALONE IN PATIENTS WITH ADVANCED PANCREATIC CANCER

被引：0

作者：

Cho, J. Y. ^{[1
]}

Lim, J. Y. ^{[1
]}

Lee, S. J. ^{[1
]}

Lee, D. K. ^{[1
]}

Park, J. S. ^{[1
]}

Yoon, D. S. ^{[1
]}

Min, Y. H. ^{[2
]}

机构：

[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Seoul, South Korea

[2] Severance Hosp, Seoul, South Korea

来源：

ANNALS OF ONCOLOGY | 2012年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：240 / 240

页数：1

共 50 条

[1] Gemcitabine in combination with capecitabine compared with gemcitabine combined with erlotinib in locally advanced or metastatic pancreatic cancer
Khatri, P.
Kumari, P.
Beniwal, S.
Samdariya, S.
ANNALS OF ONCOLOGY, 2016, 27 : 92 - 92
[2] Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
Lim, Jae Yun
Cho, Jang Ho
Lee, Se Joon
Lee, Dong Ki
Yoon, Dong Sup
Cho, Jae Yong
CANCER RESEARCH AND TREATMENT, 2015, 47 (02): : 266 - 273
[3] Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Moore, Malcolm J.
Goldstein, David
Hamm, John
Figer, Arie
Hecht, Joel R.
Gallinger, Steven
Au, Heather J.
Murawa, Pawel
Walde, David
Wolff, Robert A.
Campos, Daniel
Lim, Robert
Ding, Keyue
Clark, Gary
Voskoglou-Nomikos, Theodora
Ptasynski, Mieke
Parulekar, Wendy
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 1960 - 1966
[4] Randomized controlled trial of gemcitabine in combination with UFT versus gemcitabine alone in patients with advanced pancreatic cancer.
Ohkawa, S
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 346S - 346S
[5] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
Hwang, In Gyu
Jang, Joung-Soon
Oh, Sung Yong
Lee, Suee
Kwon, Hyuk Chan
Lee, Gyeong Won
Go, Seil
Kang, Myoung Hee
Cha, Young Joo
Kang, Jung Hun
INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2371 - 2376
[6] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
In Gyu Hwang
Joung-Soon Jang
Sung Yong Oh
Suee Lee
Hyuk Chan Kwon
Gyeong Won Lee
Seil Go
Myoung Hee Kang
Young Joo Cha
Jung Hun Kang
Investigational New Drugs, 2012, 30 : 2371 - 2376
[7] Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer
Kulke, Matthew H.
Blaszkowsky, Lawrence S.
Ryan, David P.
Clark, Jeffrey W.
Meyerhardt, Jeffrey A.
Zhu, Andrew X.
Enzinger, Peter C.
Kwak, Eunice L.
Muzikansky, Alona
Lawrence, Colleen
Fuchs, Charles S.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4787 - 4792
[8] Gemcitabine and oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer
All, M.
Carillio, G.
Mazzola, A.
Bagnato, S.
Di Leo, M. G.
Fallica, G.
Anna, Aiello R.
Chiarenza, M.
Caruso, M.
ANNALS OF ONCOLOGY, 2006, 17 : XI52 - XI52
[9] Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
Heinemann, Volker
Quietzsch, Detlef
Gieseler, Frank
Gonnermann, Michael
Schoenekaes, Herbert
Rost, Andreas
Neuhaus, Horst
Haag, Caroline
Clemens, Michael
Heinrich, Bernard
Vehling-Kaiser, Ursula
Fuchs, Martin
Fleckenstein, Doris
Gesierich, Wolfgang
Uthgenannt, Dirk
Einsele, Hermann
Holstege, Axel
Hinke, Axel
Schalhorn, Andreas
Wilkowski, Ralf
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3946 - 3952
[10] Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
Louvet, C
Labianca, R
Hammel, P
Lledo, G
Zampino, MG
André, T
Zaniboni, A
Ducreux, M
Aitini, E
Taïeb, J
Faroux, R
Lepere, C
de Gramont, A
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3509 - 3516

← 1 2 3 4 5 →